Abstract Details

Title Preclinical Pharmacology and Pharmacodynamic Interactions of SAGE-547: Relevance to Super Refractory Status Epilepticus (SRSE).

Topic Neurocritical Care

Presentation(s) P6 - (-)

Poster/Presentation
Number 068

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
	No disclosure on file
	No disclosure on file
Gabriel M. Belfort, MD (BlueRock Therapeutics)	Dr. Belfort has received personal compensation for serving as an employee of Praxis Precision Medicines. Dr. Belfort has received stock or an ownership interest from Praxis Precision Medicines. Dr. Belfort has received intellectual property interests from a discovery or technology relating to health care.
James Doherty, PhD (Sage Therapeutics)	Dr. Doherty has received personal compensation for serving as an employee of Sage Therapeutics. Dr. Doherty has received stock or an ownership interest from Sage Therapeutics.

��ɫ��